Stephen L. Sabba, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 12,816 shares at $77.13 ($988K) on 2023-05-10, disclosed to the SEC on 2023-05-12.
Open-market sale of $988k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $77.13 | 6,408 | $494K | 50.0% |
| 2 | $77.13 | 6,408 | $494K | 50.0% |
| Total | $77.13 avg | 12,816 | $988K | 100% |
| Filing → |
| LGND | SELL | 2026-03-05 | $410K | — | Filing → |
| LGND | SELL | 2024-03-07 | $281K | — | Filing → |
| LGND | SELL | 2021-02-11 | $6.0M | — | Filing → |